Alfred Sandrock

Insider Reports History

Entity
Individual
Location
14 Cambridge Center, Cambridge, MA
Signature
/s/ Scott MacDonald, as Attorney-in-Fact for Alfred Sandrock
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alfred Sandrock:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOGEN INC. Head of Research & Development Common Stock 10.2K $2.52M $248.00 Jun 7, 2021 Direct
Voyager Therapeutics, Inc. President and CEO, Director Common Stock 431K $1.48M $3.43 Apr 2, 2025 Direct
Voyager Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 290K Feb 21, 2025 Direct

Insider Reports Filed by Alfred Sandrock

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYGR Voyager Therapeutics, Inc. Apr 2, 2025 1 -$37.3K 4 Apr 4, 2025 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Feb 20, 2025 3 -$49.6K 4 Feb 24, 2025 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Feb 11, 2025 1 -$74.1K 4 Feb 12, 2025 President & CEO
VYGR Voyager Therapeutics, Inc. Apr 2, 2024 1 -$119K 4 Apr 3, 2024 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Feb 21, 2024 1 -$97.2K 4 Feb 22, 2024 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Feb 9, 2024 2 $0 4 Feb 16, 2024 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Apr 3, 2023 1 -$58.2K 4 Apr 5, 2023 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Feb 17, 2023 2 $0 4 Feb 22, 2023 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Mar 22, 2022 2 $0 4 Mar 23, 2022 President and CEO, Director
VYGR Voyager Therapeutics, Inc. Feb 7, 2022 1 $0 4 Feb 9, 2022 Director
VYGR Voyager Therapeutics, Inc. Feb 7, 2022 0 $0 3 Feb 9, 2022 Director
BIIB BIOGEN INC. Jun 7, 2021 1 -$3.38M 4 Jun 9, 2021 Head of Research & Development